Abstract:Objective To explore the value of the Aging Males' Symptoms Scale (AMS) score in predicting the abnormality of serum testosterone-related markers [total testosterone (TT),sex hormone binding globulin (SHBG),luteinizing hormone (LH),calculated free testosterone (cFF),free testosterone index (FTI) and testosterone secretion index (TSI)] in community-dwelling middle-aged and elderly men,in order to provide a reference for clinical screening and diagnosis of LOH.Methods According to the economic characteristics and people's way of life,the communities in Zunyi City,China were divided into three layers:urban communities,township communities and rural communities.From each layer,7 communities/neighborhood committees/villages were randomly selected as the sampling places at a ratio of 1 ∶ 10 from August to September 2013 by stratified and cluster sampling.And from these places,a total of 1 166 qualifying data were collected from male residents aged 20 or over.Based on the serum testosterone-related markers levels of 227 20-39-year-old residents,the abnormal cut-off points of male serum testosterone-related markers were established.The data of 939 males aged 40 or over were employed to evaluate the value of AMS sore in predicting the abnormality of serum testosterone-related markers.The residents were surveyed by a self-developed questionnaire consisting of demographic data,family medical history,medical history,and AMS score (LOH symptoms were identified by AMS score ≥27,and residents with AMS score ＜27 were considered to have no LOH symptoms).The serum TT,SHBG,LH were measured,and cFT,FTI and TSI were calculated.Results Of the 939 males aged 40 or over,628 (66.9％) had LOH symptoms,36 (3.8％) had abnormal TT (25 were accompanied by concomitant LOH symptoms),203 (21.6％) had abnormal SHBG (155 were accompanied by concomitant LOH symptoms),57 (6.1％) had abnormal LH (53 were accompanied by concomitant LOH symptoms),136 (14.5％) had abnormal cFT (110 were accompanied by concomitant LOH symptoms),271 (28.9％) had abnormal FTI (213 were accompanied by concomitant LOH symptoms),249 (26.5％) had abnormal TSI (200 were accompanied by concomitant LOH symptoms).There was no significant difference in TT between residents with LOH symptoms and those without (P ＞ 0.05).Residents with LOH symptoms had higher SHBG and LH,but lower cFT,FTI and TSI compared with those without (P ＜ 0.05).The prevalence of abnormal TT did not differ significantly between residents with LOH symptoms and those without (P ＞ 0.05).The prevalence of abnormal SHBG,LH,cFT,FTI and TSI was found to be higher in residents with LOH symptoms (P ＜ 0.05).The accuracy of AMS score (≥27) for predicting abnormal TT was low (34.61％),and the accuracy of AMS score (≥27) for predicting abnormal FTI and TSI were high (49.63％,49.20％ respectively).The Kappa value of AMS score for predicting abnormal TT was 0.003 (P =0.739).And its Kappa value for predicting the abnormal SHBG,LH,cFT,FTI and TSI were respectively 0.069,0.049,0.065,0.118,0.123 (all P ＜ 0.01).Conclusion The AMS score is less valuable in predicting TT abnormalities,but it is good for predicting FTI and TSI abnormalities.

Study of INSL3 for the clinical application in the diagnosis of male late onset hypogonadism

Survey for Late-Onset Hypogonadism among Old and Middle-Aged Males in Shanghai Communities

Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men from a Community of China

Clinical Validation of Screening Scales for Late Onset of Hypogonadism in Chinese Males

The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort

The Epidemiological Characteristics of Late-Onset Hypogonadism in Chinese Middle-Aged and Elderly Men: Two Cross-Sectional Studies in the Same Community.

Decreased Testosterone Secretion Index and Free Testosterone Level with Multiple Symptoms for Late-Onset Hypogonadism Identification: a Nationwide Multicenter Study with 5980 Aging Males in China.

Surveys of serum reproductive hormone levels and the prevalence rates of late onset of hypogonadism in Chinese aging males

The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism

Comparing Calculated Free Testosterone with Total Testosterone for Screening and Diagnosing Late-Onset Hypogonadism in Aged Males: A Cross-Sectional Study

Late-onset Hypogonadism among Old and Middle-Aged Males in a Rural Community of Zhejiang Province

Association of Symptomatic Late-Onset Hypogonadism and Lower Urinary Tract Symptoms in Aging Males: a Community-Based Study

Serum Sex Hormone-Binding Globulin is Associated with Symptomatic Late-Onset Hypogonadism in Aging Rural Males: a Community-Based Study

Role of Anti-Müllerian Hormone and Testosterone in Follicular Growth: a Cross-Sectional Study.

Significance of TSI in the diagnosis of late onset hypogonadism

Symptomatic late-onset hypogonadism in men with lower urinary tract symptoms

Are the Aging Male's Symptoms (AMS) scale and the Androgen Deficiency in the Aging Male (ADAM) questionnaire suitable for the screening of late-onset hypogonadism in aging Chinese men?

Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men

Value of the Aging Males' Symptoms Scale Score in Predicting the Abnormality of Serum Testosterone-related Markers in Community-dwelling Middle-aged and Elderly Men

P-01-003 Investigation of Prevalence Status of Erectile Dysfunction Based the Subjects of Late-Onset Hypogonadism in a Chinese Community Population